FDA Blocks Studies on COVID and Shingles Vaccines, Citing Data Concerns
The U.S. Food and Drug Administration (FDA) has blocked the publication of several studies that found COVID-19 and shingles vaccines to be safe. According to a spokesperson from the Department of Health and Human Services (HHS), the studies, which were funded by taxpayer money, concluded that serious side effects from these vaccines were rare. The studies included research on the safety of COVID-19 vaccines conducted in 2023 and 2024. Andrew Nixon, an HHS spokesperson, stated that the studies were withdrawn because the authors made broad conclusions not supported by the underlying data. The FDA's decision aims to maintain the integrity of its scientific process. One study, which was accepted by a peer-reviewed journal, was later withdrawn, raising concerns about transparency and the agency's decision-making process. 
